Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3/5
Changchun BCHT Biotechnology C (688276 CH)
Watchlist
35
Analysis
Health Care
•
China
Changchun BCHT Biotechnology Co. Ltd. operates as a high-tech biopharmaceutical company. The Company provides human vaccine researching, development, production, and sales services. Changchun BCHT Biotechnology markets its products throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Changchun BCHT Biotechnology C
•
27 Nov 2024 11:36
•
Issuer-paid
Sustainable Investing Surveyor - Focus on Birchtech Corporation (BCHT)
The WTR Sustainable Index was up 3.3% W/W versus the S&P 500 Index (up 1.7%), the Russell 2000 Index (up 4.5%) and the Nasdaq Index (up 1.9%).
Water Tower Research
Follow
250 Views
Share
bullish
•
United Nova Technology
•
02 Jun 2024 21:28
STAR50/STAR100 Index Rebalance: Index Committee Flip-Flops on Profitability
There are 3 changes for the STAR50 index and 9 for the STAR100. Some stocks will have same way flows from other index trackers. United Nova Tech is...
Brian Freitas
Follow
507 Views
Share
bullish
•
Baimtec Material
•
25 Feb 2024 02:00
STAR50 Index Rebalance: Three Changes a Side; One Surprise Change
There are 3 changes for the STAR50 in March. Estimated one-way turnover is 2.9% resulting in a 1-way trade of CNY 4.08bn with over 2.5x ADV to...
Brian Freitas
Follow
641 Views
Share
bearish
•
Suzhou Novosense Microelectron
•
31 Jan 2024 23:18
STAR50 Index Rebalance Preview: Sustaining Outperformance on Expected Impact
There could be 3 changes for the STAR50 Index in March. One-way turnover is estimated at 2.4% leading to a one-way trade of CNY 2.9bn. The...
Brian Freitas
Follow
639 Views
Share
bullish
•
Nexchip Semiconductor
•
20 Dec 2023 22:20
STAR50 Index Rebalance Preview: Four High Impact Changes in March
There could be 4 changes for the STAR50 Index in March. Passive trackers will need to trade between 1.2-9.7x ADV on the adds/dels. There will be...
Brian Freitas
Follow
833 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.2
x